T helper cells that produce IL-17 (T H 17 cells) promote autoimmunity in mice and have been implicated in the pathogenesis of human inflammatory diseases. At mucosal surfaces, T H 17 cells are thought to protect the host from infection, whereas regulatory T (T reg ) cells control immune responses and inflammation triggered by the resident microflora [1] [2] [3] [4] [5] . Differentiation of both cell types requires transforming growth factor-b (TGF-b), but depends on distinct transcription factors: RORct (encoded by Rorc(ct)) for T H 17 cells and Foxp3 for T reg cells [6] [7] [8] . How TGF-b regulates the differentiation of T cells with opposing activities has been perplexing. Here we demonstrate that, together with pro-inflammatory cytokines, TGF-b orchestrates T H 17 cell differentiation in a concentration-dependent manner. At low concentrations, TGF-b synergizes with interleukin (IL)-6 and IL-21 (refs 9-11) to promote IL-23 receptor (Il23r) expression, favouring T H 17 cell differentiation. High concentrations of TGF-b repress IL23r expression and favour Foxp3
1 T reg cells. RORct and Foxp3 are co-expressed in naive CD4
1 T cells exposed to TGF-b and in a subset of T cells in the small intestinal lamina propria of the mouse. In vitro, TGF-binduced Foxp3 inhibits RORct function, at least in part through their interaction. Accordingly, lamina propria T cells that coexpress both transcription factors produce less IL-17 (also known as IL-17a) than those that express RORct alone. IL-6, IL-21 and IL-23 relieve Foxp3-mediated inhibition of RORct, thereby promoting T H 17 cell differentiation. Therefore, the decision of antigen-stimulated cells to differentiate into either T H 17 or T reg cells depends on the cytokine-regulated balance of RORct and Foxp3.
When T lymphocytes are exposed to microbial antigens, they acquire diverse effector functions depending on which cytokines are produced by activated cells of the innate immune system 12 . Differentiation of pro-inflammatory T H 17 cells requires the presence of IL-23, which is produced by activated dendritic cells [13] [14] [15] . In vitro, however, T H 17 cell differentiation is independent of IL-23 and is induced by TGF-b plus IL-6 or IL-21 (refs 6, 9-11) . Both in vitro and in vivo differentiation of the T H 17 cell lineage require the upregulation of the orphan nuclear receptor RORct
7
. TGF-b is also required to restrain inflammatory autoimmune responses 16 . Among its numerous properties is its ability to induce expression of Foxp3 in naive antigen-stimulated T cells, endowing the cells with regulatory or suppressor function 8 . Thus, TGF-b can induce both regulatory and pro-inflammatory T cells, depending on whether pro-inflammatory cytokines such as IL-6 and, potentially, IL-23 are present 11, 17 . Treatment of antigen-receptor-stimulated T cells with TGF-b alone induces expression of both Foxp3 and RORct, but not of IL-17 (refs 7, 11) . After such treatment, a significant proportion of cells co-expressed the two transcription factors (Fig. 1a and Supplementary  Fig. 1a ). To determine whether co-expression also occurs in vivo, we examined CD4 To investigate how Foxp3 may influence T H 17 cell differentiation, we asked whether its induction would influence the expression of IL-17 in TGF-b-stimulated T cells. In naive T cells that had been transduced with a retroviral vector encoding RORct, we found that, whereas IL-6 augmented the proportion of RORct-IRES-GFP 1 cells that expressed IL-17, TGF-b had a profound inhibitory effect even when added one day after transduction (Fig. 2a, b) . Addition of TGF-b was followed by a sharp increase in expression of Foxp3 in the CD4 1 T cells, and both the level of Foxp3 mRNA and proportion of Foxp3 1 cells were not affected by the expression of RORct (Fig. 2c) .
To determine whether the inhibitory effect of TGF-b on RORct is mediated by Foxp3, we knocked down expression of Foxp3 by using a short hairpin RNA (shRNA) vector. TGF-b-induced Foxp3 expression was reduced by the Foxp3-specific shRNA vector, but not by control hairpin vectors (Fig. 2c) . Accordingly, TGF-b-mediated inhibition of RORct-directed IL-17 expression was partially reversed by Foxp3 knockdown (Fig. 2d) . Consistent with the idea that this inhibition was mediated by Foxp3 upregulation, the most pronounced rescue of IL-17 expression occurred in cells that had lost the most Foxp3 expression ( Supplementary Fig. 3 ). Thus, Foxp3 induced by TGF-b inhibits the function of RORct.
These results prompted us to ask whether Foxp3 interacts with RORct to inhibit its function. Using a yeast two-hybrid screen, we previously found that human FOXP3 interacts with RAR-related 21 . We therefore examined whether mouse and human Foxp3 could similarly bind to RORct, and whether such interaction was necessary for inhibition of the RORct-mediated induction of IL-17. When Flag-epitope-tagged mouse Foxp3 was co-expressed with mouse RORct in 293T cells, the two proteins were co-immunoprecipitated (Fig. 3a) , even in the presence of DNase I or ethidium bromide, suggesting that the interaction does not involve DNA. A similar interaction was observed between human RORcT and FOXP3 (Fig. 3b) . However, both mouse and human Foxp3 lacking the conserved exon 2-encoded sequence (Foxp3DEx2) had a substantially reduced association with RORct (Fig. 3a, b) . We examined the localization of the two proteins by confocal microscopy of HeLa cells transfected with Flag-tagged mouse Foxp3 constructs with or without mouse RORct. Both Foxp3 and RORct were localized in the nucleus, but Foxp3 lacking the DNA-binding forkhead domain (Foxp3DFKH) remained in the cytoplasm due to deletion of the nuclear localization signal in FKH 22 ( Supplementary Fig. 4 ). However, Foxp3DFKH translocated to the nucleus when it was co-expressed with RORct, indicating that the Foxp3-RORct interaction is independent of FKH. Accordingly, Foxp3DFKH co-immunoprecipitated with RORct in extracts of transfected 293T cells (data not shown). A combined Foxp3DEx2/DFKH mutant remained in the cytoplasm even when it was co-expressed with RORct, further indicating that Foxp3 interacts with RORct by way of the exon 2-encoded sequence ( Supplementary  Fig. 4) .
To investigate the role of the interaction between Foxp3 and RORct in the repression of RORct-induced transcription, we co-expressed these transcription factors in naive CD4
1 T cells and examined expression of IL-17. Both mouse and human Foxp3 blocked RORct-directed IL-17 expression, but full suppression required the presence of the exon 2-encoded sequence in Foxp3, suggesting that the interaction between Foxp3 and RORct is essential (Fig. 3c and Supplementary Fig. 5 ). The ability of both mouse and human Foxp3 to repress RORct-induced IL-17 expression was abrogated by deletion of the FKH domain or a point mutation in this domain (R397W) that impairs FOXP3 DNA-binding activity and was identified in X-linked immunodeficiency, polyendocrinopathy, enteropathy (IPEX) syndrome in humans 23, 24 ( Fig. 3c and Supplementary Fig. 5 ). Therefore, Foxp3 can block the activity of RORct at least in part through an interaction involving a sequence encoded by exon 2, but the requirement for an intact FKH domain suggests that its DNA-binding activity also contributes to inhibition of IL-17 expression. Thus, Foxp3 may inhibit RORct-directed transcription through a mechanism similar to that proposed for its inhibition of IL-2 expression, involving its association with NFAT1 and Runx1 (refs 25 and 26). However, Foxp3DEx2 was as effective as the full-length protein in suppressing expression of IL-2 and interferon-c (IFN-c) in primary mouse T cells, indicating that, like the naturally occurring human spliced isoform 20 , it retains regulatory functions and can, presumably, associate with both NFAT1 and Runx1 (Supplementary Fig. 6 ).
Our results suggest that Foxp3 may inhibit RORct activity on its target genes during T H 17 cell differentiation. To extend our analysis from Il17 to other potential RORct transcriptional targets, we examined the effect of TGF-b-induced Foxp3 on Il23r expression, which also requires the activity of RORct 10, 11 . Forced expression of wildtype mouse Foxp3 inhibited IL-6/IL-21-induced Il23r expression, whereas Foxp3DEx2 had less inhibitory activity (Fig. 4a) ; this is consistent with the notion that Foxp3 inhibits the function of RORct through an interaction involving the sequence encoded by exon 2. Similar results were observed with Il22 expression in response to IL-6 or IL-21 (data not shown). Expression of Il22 and of Il23r in response to either IL-6 or forced expression of RORct was also inhibited by high concentrations of TGF-b (refs 11, 27 and data not shown). However, at low concentrations, TGF-b synergized with IL-6 and IL-21 to enhance expression of Il23r mRNA (Fig. 4b) . As a consequence, addition of IL-23 to cultures containing high concentrations of TGF-b had no effect on IL-17 expression, but significantly increased the number of IL-17 1 cells and the level of IL-17 expression per cell when low concentrations of TGF-b were used (Figs 4c, d and Supplementary Fig. 7 ). In contrast, induction of T reg (Foxp3 Fig. 8 ). However, a substantial number of Foxp3 1 cells differentiated in response to TGF-b, even in the presence of IL-6, and many of these cells also expressed IL-17 ( Supplementary Fig. 9a) . Conversely, many of the IL-17
1 cells also Anti-FOXP3 Fig. 9b and data not shown); this suggests that IL-6 and IL-21 may have an additional post-translational effect on either Foxp3 or RORct.
Our data collectively suggest that T cells receiving a TGF-b signal can acquire the potential to develop into either the T reg or the T H 17 lineage. Foxp3 induction restrains the differentiation of inflammatory T H 17 cells in response to TGF-b in the absence of other proinflammatory cytokines by inhibiting the activity of RORct. In the presence of pro-inflammatory cytokines, the suppression of Foxp3 expression and inhibitory function, together with the concurrent upregulation or stabilization of RORct expression, leads to full progression towards the T H 17 lineage (Supplementary Fig. 10 ). This process may be especially relevant in the intestinal lamina propria, in which TGF-b can promote either T H 17 or T reg cell lineage differentiation, depending on its local concentration. In this setting, a fine balance between RORct and Foxp3 may be critical for immune homeostasis. In line with the observation that more Foxp3 1 T reg cells were present in the gut of RORct-deficient mice (Fig. 1b) , these mutant mice were also protected from autoimmune disease (ref. 7 and data not shown). Conversely, a decrease of Foxp3 expression and function and an increase of RORct expression tips the T reg /T H 17 balance towards the T H 17 cell lineage. This may occur in some autoimmune diseases, as suggested by the finding that an Il23r polymorphism correlates with protection from Crohn's disease 28 . These results therefore have important implications for how peripheral tolerance is maintained in the presence of potentially pro-inflammatory cytokines.
METHODS SUMMARY
Mice. C57BL/6 mice (Taconic), mice with a GFP reporter cDNA knocked in at the RORct translation initiation site 29 , mice with an IRES-YFP-Cre cDNA knocked into the 39 UTR of the Foxp3 locus (Y.P.R. et al., submitted) and Rosa26 stop2YFP (ref. 18) mice were kept in specific pathogen-free (SPF) conditions at the animal facility of the Skirball Institute. All animal experiments were performed in accordance with approved protocols for the NYU Institutional Animal Care and Usage Committee. Cell culture. Naive CD4 1 T cells were purified and cultured as described previously 7 . In brief, 1.5 3 10 6 naive CD4 1 T cells were cultured in wells of 24-well plates (or 0.7 3 10 6 cells per well in 48-well plates) containing plate-bound anti-CD3 (5 mg ml
21
) and soluble anti-CD28 (1 mg ml 21 ). Cultures were supplemented with 2 mg ml 21 anti-IL-4 (BD Pharmingen), 2 mg ml 21 anti-IFN-c (BD Pharmingen) with or without 80 U ml 21 human IL-2 (a gift from S. Reiner), 20 ng ml 21 IL-6 (eBioscience), 5 ng ml 21 TGF-b (PeproTech), 50 ng ml 21 IL-21 (R&D Systems) and 10 ng ml 21 IL-23 (eBioscience). Viral transduction was performed as described previously, unless indicated otherwise in the text 7 . T cells were isolated from the small intestinal lamina propria as described previously 7 . General. All DNA constructs were generated by PCR-based methodology and confirmed by sequencing. Retroviral production and transduction were performed as described previously 7 . Protein-protein interaction was detected by co-immunoprecipitation and confocal microscopy in 293T cells and HeLa cells. Gene expression analysis was monitored by real-time PCR with reverse transcription (RT-PCR) using gene-specific primers and probes. IL-17 and Foxp3 protein expression were examined by intracellular staining performed according to the manufacturer's protocol. Co-expression of RORct and Foxp3 was examined by immunofluorescence using anti-RORc 30 and anti-Foxp3 antibodies. 
